Support Marketplace

Dan Gorenstein is the senior reporter for Marketplace’s Health Desk, covering the business of healthcare.

Prior to Marketplace, Dan spent more than 11 years at New Hampshire Public Radio. He got his start in journalism at the Chicago Reporter; an investigative journal that examines race and class disparities in the Chicago area. He’s won numerous national and local awards, including the Society of Professional Journalist Sigma Delta Chi investigative reporting award.

You can follow him on Twitter at @dmgorenstein.

READ MORE

Features by Dan Gorenstein

Picwell executives Jay Silverstein and Jonathan Kolstad

There's a business opportunity behind open enrollment

Companies are trying to eliminate the hassle that comes with choosing insurance.
Posted In: ACA, Health care and insurance, healthcare.gov, health exchanges
An employee counts $100 notes.

How the U.S. might get to wage growth

There's plenty of job growth. Wage growth? Not so much.
Posted In: Jobs, job growth, wages, wage growth
This is what you Facebook newsfeed might look like on your mobile device. Facebook is using the space as a fundraiser for Ebola support.

Facebook will solicit donations to fight Ebola

The money will go to three groups working to combat the outbreak in West Africa.
Posted In: Facebook, Ebola, fundraiser, newsfeed, adspace
Hisham Uadadeh walks out of Leading Insurance Agency after enrolling in a health insurance plan under the Affordable Care Act.

What GOP victories mean for the Affordable Care Act

Republican gains may not mean repeal for 'Obamacare,' but other changes may occur.
Posted In: Affordable Care Act, midterm elections, Senate, Barack Obama

BARDA: The venture capital firm buried in the U.S. government

HHS is paying for expedited drug research on Ebola.
Posted In: Ebola, Ebola vaccine, BARDA
Demonstrators with the United African Congress (UAC) hold a rally for the 'Stop Ebola' movement in New York.

The Ebola fight's HR problem

How do groups recruit healthcare workers who are needed to contain the outbreak?
Posted In: Ebola, doctors, human resources, HR, west africa
Professor Adrian Hill, chief investigator of the trials with the Ebola vaccine called Chimp Adenovirus type 3 (ChAd3), holds up a vial in September in Oxford, England. Johnson & Johnson announced they will begin testing an Ebola virus vaccine.

The economics behind the rush for an Ebola vaccine

Believe it or not, experts say the profit motive is secondary.
Posted In: Ebola, Ebola vaccine, Johnson & Johnson
Barbara Smith, a nurse with Mount Sinai Health System, demonstrates Oct. 21 to health care professionals in at the Jacob K. Javits Convention Center New York City how to properly put on protective medical gear when working with someone infected with the E

The piece that's missing from new CDC guidelines

Having protective gear is part of the solution, but so is an educated workforce.
Posted In: Ebola, CDC, public health
Workers with the union 32BJ, many of them airline cabin cleaners, terminal cleaners and wheelchair attendants, participate in a class on how to better protect themselves from infectious diseases in the wake of increased concerns around the Ebola virus in

How to stop your people from freaking out about Ebola

Nearly half of Americans are “very" or "somewhat" concerned they'll contract Ebola
Posted In: Ebola training, corporate, Ebola
Ebola patient Amber Vinson arrived by ambulance Oct. 15 at Emory University Hospital in Atlanta. She was transferred after contracting the virus at Texas Heath Presbyterian Hospital while treating Thomas Eric Duncan, who has since died.

Why the Ebola patients were transferred

Both nurses infected by an Ebola patient have been sent to different hospitals.
Posted In: Ebola, Emory University, health care

Pages

With Generous Support From...